Skip to main content

Written question asked by Virendra Sharma (Labour) on Tuesday, 7 May 2024, in the House of Commons. It was due for an answer on Monday, 13 May 2024 (named day). It was answered by Maria Caulfield (Conservative) on Monday, 13 May 2024 on behalf of the Department of Health and Social Care.


Human Papillomavirus: Vaccination

Question

To ask the Secretary of State for Health and Social Care, what steps she is taking to increase HPV vaccination uptake.

Answer

National Health Service commissioned School Age Immunisation Service providers have robust catch-up plans in place for the adolescent human papillomavirus (HPV) vaccination programme based on population need, utilising opportunities from the move to one dose in September 2023.

The UK Health Security Agency (UKHSA) works closely with several charities to develop resources that can be used to raise awareness of HPV. The UKHSA also publishes annual statistics to support local NHS teams in developing plans to improve uptake and reduce inequalities for the HPV universal programme. These statistics are available at the following link:

https://www.gov.uk/government/statistics/human-papillomavirus-hpv-vaccine-coverage-estimates-in-england-2022-to-2023/human-papillomavirus-hpv-vaccination-coverage-in-adolescents-in-england-2022-to-2023#:~:text=HPV%20vaccine%20coverage%20in%20England,pandemic%20(2018%20to%202019)

NHS England has improved digital communications on vaccinations, including expanding the NHS app, and has improved access to the vaccine outside of schools through community clinics at convenient times and locations. The UKHSA also produces a number of HPV resources, which are available at the following link:

https://www.gov.uk/government/collections/hpv-vaccination-programme

Other materials are available on the UKHSA Health Publications website in a range of languages and accessible formats, which are available at the following link:

https://www.healthpublications.gov.uk/Home.html


Secondary information

Type
Written question
Reference
24881
Session
2023-24
Subjects
Vaccination Human papillomavirus
Link
View this Written question on www.parliament.uk